Investors | Almirall
Dermatology
Main Conditions
- Atopic dermatitis
- Psoriasis
- Actinic keratosis
- Acne
- Other skin conditions
Our Commitment to Science and Innovation
Financial Data
H1 2026 Financial Results
- H1 2026 Financial Results presentation
- Q1 2026 Financial Results presentation
- FY 2025 Financial Results presentation
Calendar Events
24 JUL 2026: H1 2026 Financial Results
09 NOV 2026: 9M 2026 Financial Results
Annual General Shareholders Meeting
- 07 May 2026: Annual General Meeting of Shareholders
Corporate Governance
Contact Us
Pablo Divasson del Fraile
Investors relations
Ronda General Mitre, 151 - 08022 Barcelona
investors@almirall.com
T+ 34 932 913 000
Sustainability
Committed to people and the planet.